Loopbaan van Dean Hakanson
Eerdere bekende functies van Dean Hakanson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OTONOMY | Hoofd Techniek/Wetenschap/O&O | 01-04-2015 | 31-01-2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01-07-2009 | 01-05-2010 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2008 | 01-07-2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-06-2005 | 01-01-2008 |
| GSK PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 | 01-01-2005 |
| National Accounts, Inc. | Corporate Officer/Principal | 01-01-1998 | 01-01-2005 |
Opleiding van Dean Hakanson
| University of Denver | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Verenigd Koninkrijk | 2 |
| Zwitserland | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GSK PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| National Accounts, Inc. |
- Beurs
- Insiders
- Dean Hakanson
- Ervaring
